


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.23%
-1.87%
+0.90%
+1.26%
CAI
Caris Life Sciences
$19.53
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
CAI Price Performance
$25.79 (-24.27%)
$25.58 (-23.65%)
$30 (-34.90%)
$38.22 (-48.90%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
CAI Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CAI Street Sentiment is bullish and have positive views on the near-term outlook
CAI has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 17, 2026
Initiate
Outperform
Baird
Dec 03, 2025
Initiate
Hold
Canaccord Genuity
What is CAI current stock price?
What are CAI stock strengths?
What is CAI Risk Level?
What is CAI market cap and volume?
What is CAI current Stock IQ?
Should I buy CAI stock right now?
Is CAI a Strong Buy right now?
What does a 'Strong Buy' rating mean for CAI?
What does a 'Strong Sell' rating mean for CAI?
What factors influence CAI's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
CAI
Caris Life Sciences
Current Price
$19.53

CAI Price Performance
$25.79 (-24.27%)
$25.58 (-23.65%)
$30 (-34.90%)
$38.22 (-48.90%)
CAI Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
CAI Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CAI Street Sentiment is bullish and have positive views on the near-term outlook
CAI has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
CAI Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
CAI Latest Analysis
Baird Initiates Coverage of Caris Life Sciences (CAI) with Outperform Recommendation. Fintel reports that on February 17 2026 Baird initiated coverage of Caris Life Sciences (NasdaqGS:CAI) with a Outperform recommendation. Analyst Price Forecast Suggests 87.42% Upside
Tue Feb 17, 2026
Oversold Conditions For Caris Life Sciences (CAI). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Feb 4, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.